JP2007505131A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505131A5 JP2007505131A5 JP2006526300A JP2006526300A JP2007505131A5 JP 2007505131 A5 JP2007505131 A5 JP 2007505131A5 JP 2006526300 A JP2006526300 A JP 2006526300A JP 2006526300 A JP2006526300 A JP 2006526300A JP 2007505131 A5 JP2007505131 A5 JP 2007505131A5
- Authority
- JP
- Japan
- Prior art keywords
- wisp
- antibody
- antagonist
- medicament according
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710137353 CCN family member 4 Proteins 0.000 claims 21
- 102100031173 CCN family member 4 Human genes 0.000 claims 21
- 239000003814 drug Substances 0.000 claims 17
- 239000005557 antagonist Substances 0.000 claims 11
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 208000015100 cartilage disease Diseases 0.000 claims 5
- 210000000845 cartilage Anatomy 0.000 claims 4
- 101000777560 Homo sapiens CCN family member 4 Proteins 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 210000001612 chondrocyte Anatomy 0.000 claims 3
- 210000000130 stem cell Anatomy 0.000 claims 3
- 208000024429 articular cartilage disease Diseases 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 210000001188 articular cartilage Anatomy 0.000 claims 1
- 230000003412 degenerative effect Effects 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50201303P | 2003-09-11 | 2003-09-11 | |
| PCT/US2004/029510 WO2005025603A2 (en) | 2003-09-11 | 2004-09-09 | Methods of using wisp antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505131A JP2007505131A (ja) | 2007-03-08 |
| JP2007505131A5 true JP2007505131A5 (cg-RX-API-DMAC7.html) | 2007-08-30 |
Family
ID=34312341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526300A Pending JP2007505131A (ja) | 2003-09-11 | 2004-09-09 | Ｗｉｓｐアンタゴニストの使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060292150A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1663288A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007505131A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004272066B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2536396A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005025603A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| WO2004003158A2 (en) | 2002-06-29 | 2004-01-08 | Genentech, Inc. | Methods and compositions for modulating and detecting wisp activity |
| CN102628074B (zh) * | 2005-08-19 | 2015-07-29 | 詹森生物科技公司 | 抗蛋白酶解的抗体制剂 |
| FR2900155B1 (fr) * | 2006-04-21 | 2008-06-27 | Diana Naturals Sa | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations |
| MX366804B (es) | 2012-02-11 | 2019-07-25 | Genentech Inc | Translocaciones de la r-espondina y sus metodos de uso. |
| JP2019527193A (ja) * | 2016-06-02 | 2019-09-26 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | サルコペニア及び筋損傷を治療する方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0990000B1 (en) * | 1996-11-08 | 2005-07-27 | Human Genome Sciences, Inc. | Connective tissue growth factor-3 |
| WO1999062927A1 (en) * | 1998-06-05 | 1999-12-09 | Human Genome Sciences, Inc. | Connective tissue growth factor-4 |
| AU6088900A (en) * | 1999-07-23 | 2001-02-13 | Case Western Reserve University | Novel methods and reagents useful in the treatment of osteoarthritis |
| EP1326980B1 (en) * | 2000-10-16 | 2008-03-19 | Genentech, Inc. | Methods of treatment using wisp polypeptides |
| WO2004003158A2 (en) * | 2002-06-29 | 2004-01-08 | Genentech, Inc. | Methods and compositions for modulating and detecting wisp activity |
-
2004
- 2004-09-09 EP EP04788666A patent/EP1663288A2/en not_active Withdrawn
- 2004-09-09 CA CA002536396A patent/CA2536396A1/en not_active Abandoned
- 2004-09-09 AU AU2004272066A patent/AU2004272066B8/en not_active Ceased
- 2004-09-09 JP JP2006526300A patent/JP2007505131A/ja active Pending
- 2004-09-09 WO PCT/US2004/029510 patent/WO2005025603A2/en not_active Ceased
- 2004-09-09 US US10/570,826 patent/US20060292150A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5607176B2 (ja) | 新規ペプチドおよびその用途 | |
| CN111093708B (zh) | 生物正交组合物 | |
| JP7405345B2 (ja) | 間葉系幹細胞の動員活性を有するペプチド | |
| JP2010526153A5 (cg-RX-API-DMAC7.html) | ||
| JP6890835B2 (ja) | 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用 | |
| JP2006506942A5 (cg-RX-API-DMAC7.html) | ||
| WO2015161820A1 (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| CN103030687B (zh) | 青环海蛇抗炎活性肽Hydrostatin-SN1及其编码基因和在制药中的应用 | |
| JP6640725B2 (ja) | ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す | |
| JP2002502369A (ja) | 胃腸管上部の機能を強化する方法 | |
| JP2006508099A5 (cg-RX-API-DMAC7.html) | ||
| JP7672636B2 (ja) | 間葉系幹細胞の動員活性を有するペプチド | |
| JP7261499B2 (ja) | 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用 | |
| JP2007505131A5 (cg-RX-API-DMAC7.html) | ||
| AU2018257071A1 (en) | Peptide for inducing regeneration of tissue, and use thereof | |
| CN104800885B (zh) | 一种具有趋化功能的生物活性支架的制备和应用 | |
| CN109715191A (zh) | 将赘生性细胞转化成非赘生性细胞的药物缔合物及其用途 | |
| WO2014140930A2 (en) | Compostions and methods for enhancing the therapeutic potential of stem cells | |
| CN109715190A (zh) | 将赘生性细胞转化成非赘生性细胞的生长因子受体激动剂和黏附蛋白抑制剂的药物缔合物及其用途 | |
| CN118772296A (zh) | 一种多肽药物及其在预防或治疗腹主动脉瘤中的应用 | |
| CN109265549A (zh) | 一种具有中和活性的抗人Tim-1抗体 | |
| ES2312192T3 (es) | Uso de oligomeros de acidos nucleicos de poliamida para engendrar una respuesta biologica. | |
| TWI395592B (zh) | 由聚乳酸－甘醇酸（ｐｏｌｙ（ｌａｃｔｉｃ－ｃｏ－ｇｌｙｃｏｌｉｃ ａｃｉｄ））微小球控制釋放副甲狀腺素之方法 | |
| CN109303763A (zh) | 一种生物材料负载干细胞治疗结肠炎的方法 | |
| RU2008125167A (ru) | Терапевтическое средство для ускоренного заживления кожи, содержащее в качестве активного ингредиента дезацил-грелин и его производные |